Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

Todd Neale

July 21, 2020

Advertisement

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

TCTMD’s Top 10 Most Popular Stories for October 2020

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content